A daily pill combined with chemotherapy has produced striking results in patients with advanced pancreatic cancer, with tumours becoming undetectable in about one in 12 patients and shrinking in more than 60 per cent of those treated, according to new clinical trial findings.The drug, called daraxonrasib, was tested in 61 patients whose pancreatic cancer had spread to other parts of the body. Researchers found that tumours shrank or disappeared…